On 9 October 2023, the Agency submitted an opinion [Biocidal Products Committee (BPC) opinion on the minor change to the Union authorisation of the single biocidal product ‘Pesguard® Gel’ of 9 October 2023, ECHA/BPC/395/2023 (https://echa.europa.eu/opinions-on-union-authorisation).] to the Commission on the application for minor changes to the Union authorisation for the biocidal product ‘Pesguard® Gel’ of 8 April 2022, in accordance with Article 12(4) of Implementing Regulation (EU) No 354/2013, together with a revised SPC and a revised assessment report. This opinion concluded that the increase of the concentration of two substances of concern in the product is not a minor change in accordance with Article 3(1), point (ab), of Regulation (EU) No 528/2012 and as specified in Title 2 of the Annex to Implementing Regulation (EU) No 354/2013. However, the Agency concluded that the changes related to the addition of a new manufacturing site for the active substance chlothianidin and a change in the address of the manufacturer of the two active substances are administrative changes in accordance with Article 3(1), point (aa), of Regulation (EU) No 528/2012 as specified in Title 1 of the Annex to Implementing Regulation (EU) No 354/2013, and that after the implementation of those changes, the conditions of Article 19 of Regulation (EU) No 528/2012 will still be met.
Recital 6, Regulation (EU) 2024/2199
In forcesince 4 Sep 2024